Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

A new equation to estimate glomerular filtration rate.

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).

Ann Intern Med. 2009 May 5;150(9):604-12. Erratum in: Ann Intern Med. 2011 Sep 20;155(6):408.

2.

Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden.

Geistanger A, Arends S, Berding C, Hoshino T, Jeppsson JO, Little R, Siebelder C, Weykamp C; IFCC Working Group on Standardization of Hemoglobin A1c.

Clin Chem. 2008 Aug;54(8):1379-85. doi: 10.1373/clinchem.2008.103556. Epub 2008 Jun 6.

3.

Cystatin C: research priorities targeted to clinical decision making.

Shlipak MG.

Am J Kidney Dis. 2008 Mar;51(3):358-61. doi: 10.1053/j.ajkd.2008.01.002. No abstract available.

PMID:
18295049
4.

Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.

Maahs DM, Ogden LG, Kretowski A, Snell-Bergeon JK, Kinney GL, Berl T, Rewers M.

Diabetes. 2007 Nov;56(11):2774-9. Epub 2007 Jul 27.

5.

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.

Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration.

Clin Chem. 2007 Apr;53(4):766-72. Epub 2007 Mar 1.

6.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
7.

Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.

Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, Satterfield S, Cummings SR, Newman AB, Fried LF.

J Am Soc Nephrol. 2006 Jan;17(1):254-61. Epub 2005 Nov 2.

8.
9.

Plasma cystatin-C and development of coronary heart disease: The PRIME Study.

Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, Ferrieres J, Juhan-Vague I, Fruchart JC, Ducimetiere P; PRIME Study Group.

Atherosclerosis. 2006 Apr;185(2):375-80. Epub 2005 Jul 25.

PMID:
16046222
10.

Cystatin C and the risk of death and cardiovascular events among elderly persons.

Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C.

N Engl J Med. 2005 May 19;352(20):2049-60.

11.

Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population.

Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J, Ehrlich J, Garg S, Eckel RH, Rewers MJ.

Diabetes Care. 2005 Feb;28(2):301-6.

PMID:
15677783
12.

Cystatin C as a marker of GFR--history, indications, and future research.

Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A.

Clin Biochem. 2005 Jan;38(1):1-8. Review.

PMID:
15607309
13.
14.

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.

Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M; Coronary Artery Calcification in Type 1 Diabetes Study.

Diabetes. 2003 Nov;52(11):2833-9. Erratum in: Diabetes. 2004 Aug;53(8):2177.

15.

Performance of serum cystatin-C versus serum creatinine in subjects with type 1 diabetes.

Buysschaert M, Joudi I, Wallemacq P, Hermans MP.

Diabetes Care. 2003 Apr;26(4):1320. No abstract available.

PMID:
12663624
16.
17.

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.

Dharnidharka VR, Kwon C, Stevens G.

Am J Kidney Dis. 2002 Aug;40(2):221-6.

PMID:
12148093
18.

Cystatin C: an improved estimator of glomerular filtration rate?

Laterza OF, Price CP, Scott MG.

Clin Chem. 2002 May;48(5):699-707. Review.

19.

Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System.

Erlandsen EJ, Randers E, Kristensen JH.

Scand J Clin Lab Invest. 1999 Feb;59(1):1-8.

PMID:
10206092
20.

Supplemental Content

Support Center